Tdap Vaccination for Infant Caregivers

Yale University logo

Yale University

Status

Completed

Conditions

Vaccination
Pertussis

Treatments

Other: Survey

Study type

Observational

Funder types

Other

Identifiers

NCT01233401
1005006837

Details and patient eligibility

About

This study evaluates whether offering Tetanus, diphteria and acellular pertussis (Tdap) vaccine to caregivers of newborn infants during pediatric well child visits increase the caregivers' vaccination rates.

Enrollment

102 patients

Sex

All

Ages

18 to 64 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 18-64 years old
  • English or Spanish speaking

Exclusion criteria

Do not speak English or Spanish

Trial design

102 participants in 2 patient groups

Mothers
Treatment:
Other: Survey
Other Infant Caregivers
Description:
Includes fathers, grandparents, and other adults who are infant caregivers
Treatment:
Other: Survey

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems